Correlation Between Revelation Biosciences and Lexaria Bioscience
Can any of the company-specific risk be diversified away by investing in both Revelation Biosciences and Lexaria Bioscience at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Revelation Biosciences and Lexaria Bioscience into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Revelation Biosciences and Lexaria Bioscience Corp, you can compare the effects of market volatilities on Revelation Biosciences and Lexaria Bioscience and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Revelation Biosciences with a short position of Lexaria Bioscience. Check out your portfolio center. Please also check ongoing floating volatility patterns of Revelation Biosciences and Lexaria Bioscience.
Diversification Opportunities for Revelation Biosciences and Lexaria Bioscience
0.34 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Revelation and Lexaria is 0.34. Overlapping area represents the amount of risk that can be diversified away by holding Revelation Biosciences and Lexaria Bioscience Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Lexaria Bioscience Corp and Revelation Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Revelation Biosciences are associated (or correlated) with Lexaria Bioscience. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Lexaria Bioscience Corp has no effect on the direction of Revelation Biosciences i.e., Revelation Biosciences and Lexaria Bioscience go up and down completely randomly.
Pair Corralation between Revelation Biosciences and Lexaria Bioscience
Given the investment horizon of 90 days Revelation Biosciences is expected to generate 1.61 times more return on investment than Lexaria Bioscience. However, Revelation Biosciences is 1.61 times more volatile than Lexaria Bioscience Corp. It trades about -0.1 of its potential returns per unit of risk. Lexaria Bioscience Corp is currently generating about -0.27 per unit of risk. If you would invest 115.00 in Revelation Biosciences on August 30, 2024 and sell it today you would lose (39.50) from holding Revelation Biosciences or give up 34.35% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Very Weak |
Accuracy | 98.44% |
Values | Daily Returns |
Revelation Biosciences vs. Lexaria Bioscience Corp
Performance |
Timeline |
Revelation Biosciences |
Lexaria Bioscience Corp |
Revelation Biosciences and Lexaria Bioscience Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Revelation Biosciences and Lexaria Bioscience
The main advantage of trading using opposite Revelation Biosciences and Lexaria Bioscience positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Revelation Biosciences position performs unexpectedly, Lexaria Bioscience can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Lexaria Bioscience will offset losses from the drop in Lexaria Bioscience's long position.Revelation Biosciences vs. Virax Biolabs Group | Revelation Biosciences vs. Kiora Pharmaceuticals | Revelation Biosciences vs. ZyVersa Therapeutics | Revelation Biosciences vs. Sonnet Biotherapeutics Holdings |
Lexaria Bioscience vs. Revelation Biosciences | Lexaria Bioscience vs. Zura Bio Limited | Lexaria Bioscience vs. Phio Pharmaceuticals Corp | Lexaria Bioscience vs. ZyVersa Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Other Complementary Tools
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Stocks Directory Find actively traded stocks across global markets | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. |